Ribozyme Pharmaceuticals, Inc. Appoints Dr. Nassim Usman to Chief Scientific Officer and Vice President, R&D

31-Jan-2002
BOULDER, Colorado, Jan. 30 -- Ribozyme Pharmaceuticals, Inc. announced today the promotion of Dr. Nassim Usman to Chief Scientific Officer and Vice President, Research and Development at Ribozyme Pharmaceuticals, Inc. Dr. Usman is a pioneer in developing the chemistry and biochemistry of nucleic acids and is credited with the development of a method for the synthesis of RNA that is used throughout the industry. Prior to joining RPI in 1992, Dr. Usman was a NIH Fogarty and Nserc Postdoctoral Fellow and Scientist in the Departments of biology and Chemistry at the Massachusetts Institute of Technology. During his 10 years at RPI, Dr. Usman has been responsible for the design and synthesis of several stabilized ribozymes that are the basis for RPI's current product candidates. His breadth of experience also includes the development of a large patent portfolio, authoring 80 publications covering nucleic acids, building the manufacturing process at RPI and instituting partnerships for the development of HEPTAZYME(TM) and ANGIOZYME(R) programs. In addition, he was a founder of atugen AG and is a member of their Board of Directors. "We are delighted to have a person of Nassim's caliber with such outstanding qualifications and experience that will help move RPI into a leadership position within the biotherapeutic industry," stated Howard W. Robin, President and CEO at RPI. "We look forward to the further clinical development and ultimately the commercialization of RPI's first product that will confirm that this exciting technology works in patients, and will help to improve the diagnosis and characterization of disease, leading to better health treatment in cancer and hepatitis."

Other news from the department people

Most read news

More news from our other portals

Discover the latest developments in battery technology!

See the theme worlds for related content

Topic world Synthesis

Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.

15+ products
4 whitepaper
15+ brochures
View topic world

Topic world Synthesis

Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.

15+ products
4 whitepaper
15+ brochures